Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2026-01-07 | Jefferies | Buy | Buy | Hold | $22.95 | Monte Rosa Therapeutics price target raised to $31 from $22… | TheFly |
| 2026-01-07 | Cowen & Co. | Buy | Buy | Hold | $23.28 | TD Cowen on Monte Rosa Therapeutics (GLUE): 'the overall da… | StreetInsider |
| 2026-01-07 | Wedbush | Outperform | Outperform | Hold | $24.4357 | Monte Rosa Therapeutics price target raised to $37 from $26… | TheFly |
| 2025-12-17 | Jefferies | Buy | Buy | Hold | $18.66 | Monte Rosa Therapeutics (GLUE) PT Raised to $22 at Jefferies | StreetInsider |
| 2025-12-16 | Wells Fargo | Overweight | Overweight | Upgrade | $16.45 | Monte Rosa Therapeutics upgraded to Overweight from Equal W… | TheFly |
| 2024-10-28 | Cowen & Co. | Buy | Buy | Hold | $9.7568 | TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (… | StreetInsider |
| 2024-10-28 | Piper Sandler | Overweight | Overweight | Hold | $11.45 | Monte Rosa Therapeutics price target raised to $20 from $16… | TheFly |
| 2024-08-12 | Wells Fargo | Overweight | Overweight | Hold | $3.94 | Monte Rosa Therapeutics price target lowered to $17 from $1… | TheFly |
| 2024-06-28 | Cowen & Co. | Buy | Buy | Hold | $3.74 | TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (… | StreetInsider |
| 2024-06-28 | Piper Sandler | Overweight | Overweight | Hold | $3.74 | Piper Sandler Reiterates Overweight Rating on Monte Rosa Th… | StreetInsider |